22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
22nd Century Overview
View Presentation
22nd Century Overview of GVB Biopharma Acquisition
View Presentation
Our Hops Franchise and Market Overview
View Presentation
22nd Century Group, Inc.
500 Seneca Street, Suite 507
Buffalo, NY 14204
T: 716-270-1523
Contact Us
Mei Kuo
22nd Century Group, Inc.
Director, Communications & Investor Relations
T: 716-300-1221
mkuo@xxiicentury.com
Darrow Associates Investor Relations
Matt Kreps
T: 214-597-8200
mkreps@darrowir.com
Continental Stock and Transfer Company
1 State Street, 30th Floor
New York, NY 10004
T: 212-509-4000
cstmail@continentalstock.com